Some studies on the expression of VISTA in pancreatic cancer tissue have demonstrated that VISTA is predominantly expressed and upregulated in the high-density-infiltrating immune cells but minimal in human pancreatic cancer (PC) cells, as well as the potential of VISTA as a critical target for pancreatic cancer immunotherapy [17, 23]. Here, VSIR is linked to pancreatic neoplasm.